In this study, we showed that both treatment of AS1411 and NCL silencing by siRNA decreased Akt1 in glioma cells, which is consistent with previous studies [48–49], and suggest the down-regulation of the Akt1 is one of the mechanisms that responsible for AS1411-induced migration and invasion inhibition of glioma cells. The gene discussed is NUCLEOLIN; the disease is central nervous system cancer.